BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 31203998)

  • 21. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
    Czuchlewski DR; Peterson LC
    Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predisposition to pediatric and hematologic cancers: a moving target.
    Malkin D; Nichols KE; Zelley K; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognizing familial myeloid leukemia in adults.
    Nickels EM; Soodalter J; Churpek JE; Godley LA
    Ther Adv Hematol; 2013 Aug; 4(4):254-69. PubMed ID: 23926458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germ line predisposition to myeloid malignancies appearing in adulthood.
    Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
    Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
    Trottier AM; Feurstein S; Godley LA
    Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis, genetics, and management of inherited bone marrow failure syndromes.
    Alter BP
    Hematology Am Soc Hematol Educ Program; 2007; ():29-39. PubMed ID: 18024606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited predisposition to acute myeloid leukemia.
    Godley LA
    Semin Hematol; 2014 Oct; 51(4):306-21. PubMed ID: 25311743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
    Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying patients with genetic predisposition to acute myeloid leukemia.
    Obrochta E; Godley LA
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Germline Predisposition to Myeloid Neoplasms.
    Thompson C; Ariagno S; Kohorst MA
    Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
    Quesada AE; Routbort MJ; DiNardo CD; Bueso-Ramos CE; Kanagal-Shamanna R; Khoury JD; Thakral B; Zuo Z; Yin CC; Loghavi S; Ok CY; Wang SA; Tang Z; Bannon SA; Benton CB; Garcia-Manero G; Kantarjian H; Luthra R; Medeiros LJ; Patel KP
    Am J Hematol; 2019 Jul; 94(7):757-766. PubMed ID: 30963592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predisposition and progression of myelodysplastic syndromes].
    Makishima H
    Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.
    Duployez N; Lejeune S; Renneville A; Preudhomme C
    Expert Rev Hematol; 2016 Dec; 9(12):1189-1202. PubMed ID: 27819178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
    Wimmer K; Rosenbaum T; Messiaen L
    Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nervous system (NS) Tumors in Cancer Predisposition Syndromes.
    Patil P; Pencheva BB; Patil VM; Fangusaro J
    Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor mutations as a cause of familial myeloid neoplasms.
    Churpek JE; Bresnick EH
    J Clin Invest; 2019 Feb; 129(2):476-488. PubMed ID: 30707109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.